Evidence for an association between the SRD5A2 (type II steroid 5α-reductase) locus and prostate cancer in Italian patients

被引:35
|
作者
Margiotti, K
Sangiuolo, F
De Luca, A
Froio, F
Pearce, CL
Ricci-Barbini, V
Micali, F
Bonafè, M
Franceschi, C
Dallapiccola, B
Novelli, G
Reichardt, JKV
机构
[1] Univ Roma Tor Vergata, Dipartimento Biopatol & Diagnost Immagini, I-00133 Rome, Italy
[2] USC, Keck Sch Med, Dept Biochem & Mol Biol, Inst Med Genet, Los Angeles, CA USA
[3] Osped Villa San Pietro, Serv Patol Clin, Rome, Italy
[4] USC, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA USA
[5] Osped CSS, IRCCS, Div Urol, San Giovanni Rotondo, Italy
[6] Univ Bologna, Dipartimento Patol Sperimentale, I-40126 Bologna, Italy
[7] Univ Roma La Sapienza, Dipartimento Med Sperimentale & Patol, Rome, Italy
[8] CSS Mendel Inst, Rome, Italy
关键词
prostate cancer; SRD5A2; gene; prostate cancer risk; polymorphic variant;
D O I
10.1155/2000/683607
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We have investigated the contributions of three polymorphic markers in the SRD5A2 gene to prostate cancer in a group of Italian patients. We have genotyped cases and controls for a polymorphic (TA), dinucleotide repeat and two functional substitutions, A49T and V89L, substituting respectively alanine with threonine at codon 49, and valine to leucine at codon 89, We found a substantially increased but not significant risk associated with the 49T mutation and a reduction of risk for the V89L substitution. In conclusion, we report on preliminary evidence for both increased and decreased risk associated with separate markers at this locus.
引用
收藏
页码:147 / 150
页数:4
相关论文
共 50 条
  • [31] Association of SRD5A2 genotype and pathological characteristics of prostate tumors
    Jaffe, JM
    Malkowicz, SB
    Walker, AH
    MacBride, S
    Peschel, R
    Tomaszewski, J
    Van Arsdalen, K
    Wein, AJ
    Rebbeck, TR
    [J]. CANCER RESEARCH, 2000, 60 (06) : 1626 - 1630
  • [32] Meta-analysis of three polymorphisms in the steroid-5-alpha-reductase, alpha polypeptide 2 gene (SRD5A2) and risk of prostate cancer
    Li, Xia
    Huang, Yan
    Fu, Xuping
    Chen, Chengwen
    Zhang, Deqiang
    Yan, Lili
    Xie, Yi
    Mao, Yanjun
    Li, Yao
    [J]. MUTAGENESIS, 2011, 26 (03) : 371 - 383
  • [33] Clinical Characterization and Analysis of the SRD5A2 Gene in Six Korean Patients with 5α-Reductase Type 2 Deficiency
    Ko, Jung Min
    Cheon, Chong-Kun
    Kim, Gu-Hwan
    Kim, Sung Hoon
    Kim, Kun Suk
    Yoo, Han-Wook
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2010, 73 (01): : 41 - 48
  • [34] The A49T mutation in the SRD5A2 gene increases risk for aggressive prostate cancer and prostatic steroid 5-alpha reductase activity
    Reichardt, J
    Makridakis, N
    Pike, M
    Crocitto, L
    Kolonel, L
    Ross, R
    Henderson, B
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A209 - A209
  • [35] Try235Phe homozygous mutation of the steroid 5-a reductase type 2 (SRD5A2) gene in a Turkish patient
    Parlak, Mesut
    Durmaz, Erdem
    Gursoy, Semin
    Bircan, Iffet
    Akcurin, Sema
    [J]. ANNALS OF SAUDI MEDICINE, 2014, 34 (03) : 254 - 256
  • [36] Mutational analysis of SRD5A2: From gene to functional kinetics in individuals with steroid 5α-reductase 2 deficiency
    Ramos, L.
    Vilchis, F.
    Chavez, B.
    Mares, L.
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2020, 200
  • [37] Characterising SRD5A2 Gene Variants in 37 Indonesian Patients with 5-Alpha-Reductase Type 2 Deficiency
    Marzuki, Nanis S.
    Idris, Firman P.
    Kartapradja, Hannie D.
    Harahap, Alida R.
    Batubara, Jose R. L.
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2019, 2019
  • [38] Male pseudohermaphroditism resulting from a novel mutation in the human steroid 5 alpha-reductase type 2 gene (SRD5A2)
    Anwar, R
    Gilbey, SG
    New, JP
    Markham, AF
    [J]. JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 1997, 50 (01): : 51 - 52
  • [39] Identification of three novel SRD5A2 mutations in Chinese patients with 5α-reductase 2 deficiency
    Cheng, Tong
    Wang, Hao
    Han, Bing
    Zhu, Hui
    Yao, Hai-Jun
    Zhao, Shuang-Xia
    Zhu, Wen-Jiao
    Zhai, Hua-Ling
    Chen, Fu-Guo
    Song, Huai-Dong
    Cheng, Kai-Xiang
    Liu, Yang
    Qiao, Jie
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2019, 21 (06) : 577 - +
  • [40] Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis
    Qiaoxin Li
    Yao Zhu
    Jing He
    Mengyun Wang
    Meiling Zhu
    Tingyan Shi
    Lixin Qiu
    Dingwei Ye
    Qingyi Wei
    [J]. Molecular Biology Reports, 2013, 40 : 3597 - 3608